Drug Profile
Artemotil
Alternative Names: Artecef; Arteether; Artether; Beta-arteether; Betamotil; SM 227; β-arteetherLatest Information Update: 30 Mar 2015
Price :
$50
*
At a glance
- Originator Shanghai Institute of Materia Medica
- Developer Brocacef Holding
- Class Antimalarials; Artemisinins; Small molecules
- Mechanism of Action Free radical stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Marketed Falciparum malaria
- Discontinued Toxoplasmosis
Most Recent Events
- 30 Mar 2015 Launched for Falciparum malaria in India (IM) before March 2015
- 30 Mar 2015 No recent reports on development identified - Registered for Falciparum malaria in France, Myanmar, Thailand, Niger, Nigeria, Sudan and Pakistan (IM)
- 14 Aug 2002 A clinical study has been added to the pharmacokinetics section